Is NCT01365169 recruiting in Houston, TX?

Yes, NCT01365169 is currently recruiting participants at its Houston, TX location. This malignant head and neck neoplasm clinical trial is actively enrolling qualified participants.

How do I join the malignant head and neck neoplasm clinical trial in Houston?

To join this clinical trial in Houston, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Houston clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Malignant Head and Neck Neoplasm Clinical Trial in Houston, TX

About This Malignant Head and Neck Neoplasm Study in Houston

The main goal of this phase of the study is to determine if objectively assessed Physical Activity (PA) levels in advanced-cancer patients are associated with health care provider (HCP)-assessed ECOG performance status and overall survival. The purpose is to advance the evidence-base for incorporating objective assessment of Physical Activity (PA) in the context of performance status assessment in advanced cancer patients.

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Diagnosis of any stage I - IV colorectal cancer or recurrent colorectal cancer (Arm 1)

Able to speak, read, and write in English (Pre-pilot phase, Arms 1-4)

Able to provide informed consent (Pre-pilot phase, Arms 1-4, PCS study)

Lives in the Houston area (Harris county or a contiguous county) (Pre-pilot phase)

Eastern Cooperative Oncology Group (ECOG) status of 0 - 2, or self-reports being up and about more than 50% of waking hours and able to provide self-care (Arm 1)

Diagnosis of any of the following cancers: stage 1-4b oropharyngeal, hypopharyngeal, nasopharyngeal, salivary gland or oral cavity; stage 3-4b laryngeal; any unknown primary head and neck cancer with cervical metastasis that will be addressed with treatment to bilateral necks and mucosa; or other head and neck cancers medically approved by one of our Radiation Oncology collaborating medical doctors (MDs) (Arms 2 and 3)

History of any cancer, other than non-melanoma skin cancer (Arm 4)

Admitted to being a current smoker or recent quitter upon admission to MD Anderson Cancer Center (MDACC) (Arm 4)

Has a valid home address and functioning home telephone number (Arm 4)

Lives in the Houston or surrounding area, or resides in this same area during the time period that coincides with this study (Arms 1-4)

Patients who will undergo curative pancreatectomy for pancreatic adenocarcinoma, pancreatic neuroendocrine tumors, or pancreatic cysts (malignant or benign) (PCS study)

Fluent in English (PCS study)

Must have telephone access and agree to engage with research personnel using telephone (PCS study)

Diagnosis of a metastatic or locally unresectable solid tumor (TAPS study)

Fluent in English (TAPS study)

Age 18 years or older (TAPS study)

ECOG performance status score between 0-3 (TAPS study)

Exclusion Criteria

Major surgery in the past 8 weeks (Arms 1 and 4)

Self-reports hypertension that is not being monitored by a physician and is not being managed with either medication, observation, or lifestyle change (Pre-pilot phase, Arms 1-3)

Overt cognitive difficulty demonstrated by not being clearly oriented to time or person or place (Arms 1-4)

Orthopedic, neurologic, or musculoskeletal disability that would interfere with the functional task of standing on a weight scale (Pre-pilot phase, Arm 2)

Not currently receiving radiation treatment for a cancer listed in the arm-specific inclusion criteria (Arms 2 and 3)

Zubrod performance status \> 2, or self-reports either not being up and about more than 50% of waking hours or unable to provide self-care (Arms 2 and 3)

Currently receiving treatment for a cancer other than those listed in the arm-specific inclusion criteria (exception: the study does not exclude those receiving treatment for non-melanoma skin cancer) (Arms 2 and 3)

History of current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g. dysphagia due to underlying neurogenic disorder) (Arm 3 only)

Active substance use disorder (diagnosed or strongly suspected) (Arm 4)

Currently enrolled in protocol 2014-0712 (PCS study)

No home access to internet (PCS study)

No home WiFi connection (PCS study)

During clinician's pre-surgical evaluation, presents with high risk for non-therapeutic resection related to cancer diagnosis (PCS study)

Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV) (PCS study)

Recent fracture or acute musculoskeletal injury that precludes the ability to fully bear weight on all 4 limbs in order to participate in an exercise intervention (PCS study)

Poorly-controlled pain with a self-reported pain score of 7/10 at the time of enrollment (PCS study)

Myopathic or rheumatologic disease that impacts physical function (PCS study)

Has a pacemaker or other internal medical device, or reports being pregnant (PCS study)

Currently enrolled in protocol 2017-0198 (PCS study)

Demonstration of overt cognitive difficulty as demonstrated by not being clearly oriented to time or person or place (TAPS study)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT01365169) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Malignant Head and Neck Neoplasm Treatment Options in Houston, TX

If you're searching for malignant head and neck neoplasm treatment options in Houston, TX, this clinical trial (NCT01365169) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced malignant head and neck neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all malignant head and neck neoplasm clinical trials near you to find additional studies recruiting in your area.

Malignant Head and Neck Neoplasm Clinical Trial in Houston, TX

Expert Care in Houston

IRB Approved

No-Cost Care

Apply for This Houston Location

Why Participate?

Simple Process